Yuya Nakamoto
Yuya Nakamoto has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Kengo Katakabe
Kyoto Animal Medical Center
2 shared publicationsMunekazu Nakaichi
The United Graduate School of Veterinary Science, Yamaguchi University
2 shared publicationsTadahisa Mashita
Kyoto Animal Medical Center
2 shared publicationsTsuyoshi Ozawa
Kyoto Animal Medical Center
2 shared publications- Akira Yabuki
Laboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Korimoto, Kagoshima 890-0065, Japan
1 shared publication - Daisuke Hasegawa
Laboratory of Veterinary Clinical Neurology, Graduate School of Nippon Veterinary and Life Science University, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 31 March 2016
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-8
In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
GM1 and GM2 gangliosidoses are progressive neurodegenerative lysosomal storage diseases resulting from the excessive accumulation of GM1 and GM2 gangliosides in the lysosomes, respectively. The diagnosis of gangliosidosis is carried out based on comprehensive findings using various types of specimens for histological, ultrastructural, biochemical and genetic analyses. Therefore, the partial absence or lack of specimens might have resulted in many undiagnosed cases. The aim of the present study was to establish immunohistochemical and immunofluorescent techniques for the auxiliary diagnosis of canine and feline gangliosidoses, using paraffin-embedded brain specimens stored for a long period. Using hematoxylin and eosin staining, cytoplasmic accumulation of pale to eosinophilic granular materials in swollen neurons was observed in animals previously diagnosed with GM1 or GM2 gangliosidosis. The immunohistochemical and immunofluorescent techniques developed in this study clearly demonstrated the accumulated material to be either GM1 or GM2 ganglioside. Immunohistochemical and immunofluorescent techniques using stored paraffin-embedded brain specimens are useful for the retrospective diagnosis of GM1 and GM2 gangliosidoses in dogs and cats.
- 31 March 2016
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-8
Open AccessIn situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
GM1 and GM2 gangliosidoses are progressive neurodegenerative lysosomal storage diseases resulting from the excessive accumulation of GM1 and GM2 gangliosides in the lysosomes, respectively. The diagnosis of gangliosidosis is carried out based on comprehensive findings using various types of specimens for histological, ultrastructural, biochemical and genetic analyses. Therefore, the partial absence or lack of specimens might have resulted in many undiagnosed cases. The aim of the present study was to establish immunohistochemical and immunofluorescent techniques for the auxiliary diagnosis of canine and feline gangliosidoses, using paraffin-embedded brain specimens stored for a long period. Using hematoxylin and eosin staining, cytoplasmic accumulation of pale to eosinophilic granular materials in swollen neurons was observed in animals previously diagnosed with GM1 or GM2 gangliosidosis. The immunohistochemical and immunofluorescent techniques developed in this study clearly demonstrated the accumulated material to be either GM1 or GM2 ganglioside. Immunohistochemical and immunofluorescent techniques using stored paraffin-embedded brain specimens are useful for the retrospective diagnosis of GM1 and GM2 gangliosidoses in dogs and cats.
- Open Access
- 1 January 2010
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 72 (12) , 1657-1660
Clinical Outcomes of Suspected Ischemic Myelopathy in Cats
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2010
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 72 (12) , 1657-1660
Open AccessClinical Outcomes of Suspected Ischemic Myelopathy in Cats
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 20 May 2008
- Published by Springer Nature in Veterinary Research Communications
- Vol. 32 (8) , 609-617
Usefulness of an early diagnosis for the favorable prognosis of fibrocartilaginous embolism diagnosed by magnetic resonance imaging in 10 Small- to Middle-Sized Dogs
Fibrocartilaginous embolism (FCE), a disorder of rapid onset featured by nonprogressive paralysis and paresis of four legs, shows clinical symptoms very similar to those of other disorders, e.g., disk herniation. We examined 10 animals diagnosed with FCE based on clinical symptoms and magnetic resonance imaging (MRI) findings in a retrospective study to examine the relationship between onset-to-diagnosis/treatment initiation time and prognosis of FCE. Statistical procedures, including Fisher’s exact probability test, were conducted. All animals in a group, in which the diagnosis was made and treatment was initiated after an elapse of P < 0.02) shorter in the group without sequelae. A significant difference was found between the groups in early diagnosis and treatment initiation. Our study indicates that the early precise diagnosis for acutely developed paralysis and paresis of four legs through testings including MRI, as well as the early onset of their treatment are important to obtain a favorable prognosis.
- 20 May 2008
- Published by Springer Nature in Veterinary Research Communications
- Vol. 32 (8) , 609-617
Usefulness of an early diagnosis for the favorable prognosis of fibrocartilaginous embolism diagnosed by magnetic resonance imaging in 10 Small- to Middle-Sized Dogs
Fibrocartilaginous embolism (FCE), a disorder of rapid onset featured by nonprogressive paralysis and paresis of four legs, shows clinical symptoms very similar to those of other disorders, e.g., disk herniation. We examined 10 animals diagnosed with FCE based on clinical symptoms and magnetic resonance imaging (MRI) findings in a retrospective study to examine the relationship between onset-to-diagnosis/treatment initiation time and prognosis of FCE. Statistical procedures, including Fisher’s exact probability test, were conducted. All animals in a group, in which the diagnosis was made and treatment was initiated after an elapse of P < 0.02) shorter in the group without sequelae. A significant difference was found between the groups in early diagnosis and treatment initiation. Our study indicates that the early precise diagnosis for acutely developed paralysis and paresis of four legs through testings including MRI, as well as the early onset of their treatment are important to obtain a favorable prognosis.